BUPRENORPHINE HYDROCHLORIDE
Generic: BUPRENORPHINE HYDROCHLORIDE
BUPRENORPHINE HYDROCHLORIDE is FDA application ANDA221145, sponsored by GLAND. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Crystallization: due to the presence of white, crystalline particulates, adhered to the side and bot
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Crystallization; identified as Buprenorphine free base
Crystallization; identified as Buprenorphine free base
Sub-potent Drug: Out-of-Specification assay results found at 3 month stability testing.
Failed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine im
Crystallization
Crystallization; identified as Buprenorphine free base